18 /100
LOW RISK
Score updated May 29, 2026

RXRX — Recursion Pharmaceuticals, Inc. Dilution Risk Tracker

Track RXRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RXRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $300M remaining capacity
🔔 Track RXRX — Get forecast alerts →

💹 Market Data

Market Cap$1.83B
Shares Outstanding524.68M
Float512.75M
Cash$654.47M
Debt$72.38M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 226.35M shares
#1 Vanguard Group Inc 47.19M shares
#2 Blackrock Inc. 38.87M shares
#3 ARK Investment Management, LLC 37.32M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest171.32M
Days to Cover14.8
% of Float33.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022
4 INSIDER TRANSACTION Apr 24, 2026
Form 4 INSIDER TRANSACTION Apr 22, 2026
4 INSIDER TRANSACTION Apr 08, 2026
4 INSIDER TRANSACTION Apr 08, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track RXRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RXRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for RXRX
📊 RXRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RXRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.